Search

Your search keyword '"Dixit, Deobrat"' showing total 208 results

Search Constraints

Start Over You searched for: Author "Dixit, Deobrat" Remove constraint Author: "Dixit, Deobrat"
208 results on '"Dixit, Deobrat"'

Search Results

1. Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma

2. IFI35 regulates non-canonical NF-κB signaling to maintain glioblastoma stem cells and recruit tumor-associated macrophages

5. The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies

6. Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions

8. A peptide encoded by upstream open reading frame of MYC binds to tropomyosin receptor kinase B and promotes glioblastoma growth in mice.

9. Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism

10. Figure S1-S6, Table S1 from β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages

11. Data from β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages

12. Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression

13. Supplementary Data 1 from Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages

14. Data from Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages

15. Table S3 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells

16. Supplementary Figures and Legends from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells

17. Data from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells

18. Supplementary Data from The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells

19. Supplementary Data 1 from The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies

20. Supplementary methods from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock

21. Data from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock

22. Data from The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells

23. Supplementary Table 2 from The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells

24. Supplementary Table 1 from The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells

25. Data from The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies

26. Supplementary reagents from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock

27. Supplementary Table 3 from The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells

28. Supplementary figures and legends from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock

29. Supplementary table S1 from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock

30. Supplementary Information from The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies

33. Supplementary Figure from β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages

35. SREBP2 maintains glioblastoma stem cells through keeping the balance between cholesterol biosynthesis and uptake

36. Sorting-nexin-10 sustains platelet-derived growth factor receptor signaling in glioblastoma stem cells via endosomal protein sorting

37. Transcription elongation factors represent in vivo cancer dependencies in glioblastoma

39. β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages

43. Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells

44. Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases

Catalog

Books, media, physical & digital resources